Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07850960 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effect of Omeprazole on Gut Microbiota in Adults With Obesity and GERD

StatusNot Yet Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This randomized, open-label, parallel-group study will evaluate the effect of short-term omeprazole therapy on gut and oral microbiota in adults aged 50-65 years with obesity and symptomatic gastroesophageal reflux disease. Participants will be randomized 1:1 to receive omeprazole 20 mg once daily for 14 days plus standard non-pharmacological recommendations for gastroesophageal reflux disease, or standard non-pharmacological recommendations alone. Clinical and laboratory assessments will be performed at baseline and after 14 days. Stool and saliva samples will be collected to assess gut and oral microbiota, and blood samples will be collected for laboratory biomarkers.
Trial Details
NCT Number NCT07850960
Lead Sponsor Federal State Budgetary Scientific Institution
Conditions
(from sponsor)		 Obesity & Overweight, Gastroesophageal Reflux Disease
Related terms Gastroesophageal Reflux, Obesity, Overweight
Enrollment 26 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov